Should Enoxaparin (Clexane) Be Withheld the Night Before ERCP?
Yes, enoxaparin (Clexane) must be withheld at least 24 hours before ERCP with sphincterotomy or other high-risk interventions. For patients at high thrombotic risk requiring bridging anticoagulation, the last dose of therapeutic LMWH should be given at least 24 hours prior to the procedure 1.
Risk Stratification for ERCP
ERCP procedures fall into different bleeding risk categories:
Low-Risk ERCP (Continue Anticoagulation)
- Diagnostic ERCP
- ERCP with biliary or pancreatic stenting without sphincterotomy 2
High-Risk ERCP (Withhold Anticoagulation)
- ERCP with sphincterotomy
- ERCP with balloon sphincteroplasty
- ERCP with ampullectomy 2
Management Algorithm Based on Thrombotic Risk
For Patients at Low Thrombotic Risk:
- Stop enoxaparin 24 hours before high-risk ERCP
- Resume therapeutic dose the day after the procedure once adequate hemostasis is achieved
- No bridging therapy needed 1
For Patients at High Thrombotic Risk (requiring bridging):
High thrombotic risk includes:
- Non-valvular atrial fibrillation with CHADS-VASc score >5
- Metallic mitral valve
- Prosthetic valve with atrial fibrillation
- <3 months after venous thromboembolism
- Severe thrombophilia 2
Protocol:
- Stop warfarin 5 days before ERCP
- Start therapeutic dose LMWH 2 days after stopping warfarin
- Give last dose of LMWH at least 24 hours before the procedure 1
- Check INR before procedure to ensure <1.5
- Resume warfarin the night of the procedure with usual dose
- Restart therapeutic LMWH the day after the procedure
- Continue LMWH until therapeutic INR achieved 1
Critical Timing Considerations
The 24-hour window is the minimum recommended interval. However, emerging evidence suggests this may not be conservative enough in all patients:
- Research shows that anti-Xa activity can remain elevated beyond 24 hours in some patients, with 11 of 19 patients showing residual anticoagulant activity despite meeting the 24-hour guideline 3
- One patient had anti-Xa levels still in the therapeutic range after 24 hours 3
When to Consider Longer Withholding Period:
- Renal impairment (enoxaparin is renally cleared)
- Obesity (altered pharmacokinetics)
- Extended duration of therapy (potential accumulation)
In these situations, consider checking anti-Xa levels before the procedure if available, or extending the withholding period to 48 hours for added safety.
Common Pitfalls to Avoid
Don't confuse prophylactic with therapeutic dosing: The 24-hour rule applies to therapeutic doses (1 mg/kg twice daily or 1.5 mg/kg once daily). Prophylactic doses have different kinetics.
Don't assume all ERCPs are high-risk: Simple stent placement without sphincterotomy can proceed without stopping anticoagulation 2.
Don't bridge low-risk patients: Bridging anticoagulation is only for high thrombotic risk patients and actually increases bleeding risk unnecessarily in others 1.
Don't forget to check renal function: Enoxaparin clearance is significantly prolonged in renal impairment, requiring longer withholding periods.